This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Metabolic Syndrome
and you are
between 45 and 70
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The primary objective is to evaluate the efficacy of FaseMETS for 6 consecutive months in lowering serum lipids and glucose in subjects with Metabolic Syndrome; The secondary objectives of the trial are: - to evaluate the potential benefit after 3 months of therapy (by an interim analysis) - to evaluate the safety of FaseMETS

Provided treatments

  • : Daily administration: 2 tablets FaseMETS a day

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02912325. The sponsor of the trial is MDM S.p.A. and it is looking for 34 volunteers for the current phase.
Official trial title:
A Pilot, Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS in Metabolic Syndrome